Canada approves a lactase for use in low-lactase preparations and some dairy products
On February 2023, 2, Health Canada issued document NOM/ADM-6, which intends to revise the list of permitted food enzymes and approve lactase from Bacillus subtilis DH0193 for low lactase preparations and parts Dairy.
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
2026-07-13
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
The EU evaluates the safety of a D-tagnose 3-epimerase
-
The EU identified six active substances that do not require MRL review
-
The EU evaluates the safety of α-amylase produced by the transgenic Bacillus subtilis strain AR-651
-
The EU evaluates the safety of phospholipase A10 produced by the transgenic Streptomyces viasura strain AS-2
-
The EU modifies Clostridium butyrate FERM BP-2789 as a condition for the authorization of feed additives for fattening chickens, laying hens and small poultry
-
The EU evaluates the safety of a D-tagnose 3-epimerase
-
The EU modifies Clostridium butyrate FERM BP-2789 as a condition for the authorization of feed additives for fattening chickens, laying hens and small poultry
-
The EU evaluates the safety of phospholipase A10 produced by the transgenic Streptomyces viasura strain AS-2
-
In 2022, Japan notified China's food violations of the Japanese Food Sanitation Law
-
The European Union approves meerschaum clay as a feed additive for species such as ruminants and salmon
Recommend Reading
-
Lilly’s Indiana Investment Puts API Capacity at the Center of Obesity Drug Competition
-
FDA’s Warning to Compounders Raises the Stakes for API and Excipient Suppliers
-
BASF’s Price Increase Shows Pharma Excipients Are Still Exposed to Chemical Cost Pressure
-
AstraZeneca to Invest $2 Billion in New U.S. Biologics Facilities
-
West Asia Tensions Squeeze Pharma Raw Materials
-
Weak demand leads to continuous decline in ammonium sulfate prices in China (9.5-9.11)
-
Downstream Demand Weak, DMF Market Primarily Operates at a Weak Level
-
Strong Supply and Weak Demand Lead to Lower Dichloromethane Prices in China
-
Terminal demand weak, adipic acid market trend declines
-
China's acetone export volume continued to grow from January to July 2025